Healthcare & Life Sciences
Neuvasq
Belgiumneuvasq.com
Neuvasq is a Healthcare & Life Sciences startup based in Belgium, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Neuvasq
Neuvasq is a startup based in Belgium. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Neuvasq develops first-in-class Wnt surrogate antibodies targeting Gpr124 and Reck to restore the integrity of blood-brain and blood-retina barriers, aiming to treat neurological and vascular retinal disorders.
Explore Neuvasq's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.